Statements regarding COVID-19 and ACEI/ARB use

Dear colleagues, For those that haven't received it, we wanted to forward the following Position Statement from the American Society of Pediatric Nephrology Clinical Affairs & Practice Management Committee, in keeping with similar recent national and international organization statements. The link is here Please let us know if you have any questions or visit the NephJC website for up-to-date and peer-reviewed information: http://www.nephjc.com/news/covidace2 Additionally, since the ASPN released its position statement, the American Heart Association and American College of Cardiology have also issued a statement: https://professional.heart.org/professional/ScienceNews/UCM_505836_HFSAACCAHA-statement-addresses-concerns-re-using-RAAS-antagonists-in-COVID-19.jsp Thank you and stay safe. Andrew South, MD, MS, Brenner Children's Hospital/Wake Forest School of Medicine Michelle Rheault, MD, Children's Minnesota/University of Minnesota School of Medicine Joseph Flynn, MD, MS, Seattle Children's Hospital/University of Washington School of Medicine